Aminoglycoside-resistance mechanisms in multidrug-resistant Staphylococcus aureus clinical isolates

Current Microbiology

Volumn 56, Issue 6, 2008, Pages 558-562

  Kelmani Chandrakanth, R ^a   Raju, S ^a,b   Patil, S A ^c  

^a GULBARGA UNIVERSITY   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

^c NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOGLYCOSIDE MODIFYING ENZYME; BACTERIAL ENZYME; GENTAMICIN; KANAMYCIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIAL GENOME; BACTERIUM ISOLATE; CELL SHAPE; CELL SIZE; CONTROLLED STUDY; GENOTYPE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DISK DIFFUSION ANTIMICROBIAL TESTS; DNA FINGERPRINTING; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

STAPHYLOCOCCUS AUREUS;

EID: 43549106570     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-008-9123-y     Document Type: Article

References (25)

1. Asseray N, Caillon J, Roux N, et al. (2002) Different aminoglycoside-resistant phenotypes in a rabbit Staphylococcus aureus endocarditis infection model. Antimicrob Agents Chemother 46:1591-1593
2. Benveniste R, Davies J (1973) Mechanisms of antibiotic resistance in bacteria. Annu Rev Biochem 42:471-506
3. Bryan LE (1990) Two forms of antimicrobial resistance: bacterial persistence and positive function resistance. J Antimicrob Chemother 23:817-823
4. Bryan LE, Kwan S (1983) Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamycin. Antimicrob Agents Chemother 23:835-845
5. Dornbusch K, Miller GH, Hare RS, Shaw KJ, ESGAR Study Group (1990) Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. J Antimicrob Chemother 26:131-144
6. Edson RS, Terrell CL (1999) The aminoglycosides. Mayo Clin Proc 74:519-528
7. Fani R, Damiani G, Di Serio Gallori E, Grifoni A, Bazzicalupo M (1993) Use of random amplified polymorphic DNA (RAPD) for generating specific DNA probes for microorganisms. Mol Ecol 2:243-250
8. Neumann G, Veeranagouda Y, Karegoudar TB, et al. (2005) Cells of Pseudomonas putida and Enterobacter sp. adapt to toxic organic compounds by increasing their size. Extremophiles 9:163-168
9. Hancock REW (1981) Aminoglycoside uptake and mode of action with special reference to streptomycin and gentamycin. J Antimicrob Chemother 8:249-276
10. Ida T, Okamoto R, Shimauchi C, Okubo T, Kuga A, Inoue M (2001) Identification of aminoglycoside-modifying enzymes by susceptibility testing: epidemiology of methicillin-resistant Staphylococcus aureus in Japan. J Clin Microbiol 39:3115-3121
11. Mandel LJ, Murphy E, Steigbigel NH, Miller MH (1984) Gentamycin uptake in Staphylococcus aureus possessing plasmid-encoded, aminoglycoside-modifying enzymes. Antimicrob Agents Chemother 26:563-569
12. Miller MH, Edberg SC, Mandel LJ, Behar CF, Steigbigel NH (1980) Gentamycin uptake in wild type and aminoglycoside-resistant small-colony mutants of Staphylococcus aureus. Antimicrob Agents Chemother 18:722-729
13. Moorman DR, Mandeli GL (1981) Characteristics of rifampin-resistant variants obtained from clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother 20:709-713
14. Phillips I, Shannon K (1984) Aminoglycoside resistance. Br Med Bull 40:28-35
15. Phillips I, King A, Shannon K (1986) Prevalence and mechanisms of aminoglycoside resistance a ten-year study. Am J Med 80:48-55
16. Poole K (2005) Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49:479-487
17. Raju S, Gururaj Rao, Patil SA, Chandrakanth Kelmani R (2007) Increase in cell size and acid tolerance response in a stepwise adapted methicillin resistant Staphylococcus aureus mutant. World J Microbiol Biotechnol 23:1227-1232
18. Raju S, Kelmani Chandrakanth R, Patil SA (2007) High level oxacillin and gentamycin resistance with reduced susceptibility to vancomycin in Staphylococcus aureus carrying mecA and femA gene complex. Curr Microbiol 54:429-434
19. Rouch DA, Byrne ME, Kong YC, Skurray RA (1987) The aacA-aphD gentamycin and kanamycin resistance determinant of Tn4001from Staphylococcus aureus: expression and nucleotide sequence analysis. J Gen Microbiol 133:3039-3052
20. Shaw KJ, Rather PN, Hare RS, Miller GH (1993) Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev 57:138-163
21. Shelburne SA, Musher DM, Hulten K, et al. (2004) In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations. Antimicrob Agents Chemother 48:4016-4019
22. Shlaes DM, Etter L, Gutmann L (1991) Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamycin. Antimicrob Agents Chemother 35:776-779
23. Ubukata K, Yamashita N, Gotoh A, Konno M (1984) Purification and characterization of aminoglycoside-modifying enzymes from Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother 25:754-759
24. Vanhoof R, Hannecart-Pokorni E, Content J (1998) Nomenclature of genes encoding aminoglycoside-modifying enzymes. Antimicrob Agents Chemother 42:483
25. You I, Kariyama R, Zervos MJ, Kumon H, Chow JW (2000) In-vitro activity of arbekacin alone and in combination with vancomycin against gentamycin- and methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 36:37-41